Search

PNR approved for the MIA (IMP) QP oversight license

PNR Pharma currently has IMP, MIA and WDA licences authorised by the HPRA. Allowing the QP certification of both clinical and commercial supplies within the EU. As part of the expansion plans, PNR has been recently audited by the MHRA and has been approved for the MIA (IMP) QP oversight license thus allowing the import of clinical supplies from listed countries into the UK.

Let us tell you more

We will email you to start the conversation

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.